No Data
Jinyu Biotechnology Co., Ltd. Report for the first quarter of 2025
Jinyu Biotechnology Co., Ltd. 2024 Annual Report
Summary of the 2024 Annual Report of Jinyu Biotechnology Co., Ltd.
Jinyu Bio-Technology (600201.SH) released its first-quarter performance, with a net income of 76.4811 million yuan, a decrease of 27.57% year-on-year.
Jinyu Bio-Technology (600201.SH) released the first quarter report for 2025, with first quarter revenue of 3....
Huachuang Securities: In the first quarter, the issuance of vaccine batches increased significantly, and the price of macrocyclic lactone veterinary medicine Active Pharmaceutical Ingredients continues to rise.
The demand for animal health products is gradually recovering, and by 2025, the breeding sector is expected to maintain profitability. The continuity of demand for animal health products may be ensured, and the Operation in the animal health Sector is gradually establishing a turning point.
Investors Appear Satisfied With Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) Prospects
Positive Earnings Growth Hasn't Been Enough to Get Jinyu Bio-technology (SHSE:600201) Shareholders a Favorable Return Over the Last Three Years
